cream

Manufacturer
Oxygen Development
Effective date
2023-02-10
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 23:53:54

Label at a glance#

Productcream
Active ingredientOXYBENZONE, OCTINOXATE
Label structure6 sections

Indications and uses

helps prevent sunburn. Provides moderate protection against sunburn.

Dosage and administration

Apply and blend evenly onto the face. Use over Studiomakeup soft illusion Face Primer for a flawless and smooth finish

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Octinoxate 7.5

Oxybenzone 2.0

Purpose

OTC - PURPOSE SECTION

Sunscreen

Uses

INDICATIONS & USAGE SECTION

helps prevent sunburn. Provides moderate protection against sunburn.

Directions

DOSAGE & ADMINISTRATION SECTION

Apply and blend evenly onto the face. Use over Studiomakeup soft illusion Face Primer for a flawless and smooth finish

Ingredients

INACTIVE INGREDIENT SECTION

Water/Aqua, phenyl trimethicone, ethylhexyl methoxycinnamate, dimethicone, dicaprylyl ether, boron nitride, benzophenone-3, polymethylsilsesquioxane, silica, mica, aloe barbadensis leaf juice, disteardimonium hectorite, phenoxyethanol, dimethicone/PEG-10/15 crosspolymer, isododecane, sodium chloride, polyglyceryl-4 isostearate, hexyl laurate, cetyl PEG/PPG-10/1 dimethicone, propylene carbonate, dimethicone crosspolymer, polyethylene, polysilicone-11, ethylhexyglycerin, aluminum dimyristate, triehoxycaprylylsilane,disodium stearoyl glutamate, disodium EDTA, citric acid, potassium sorbate, sodium benzoate, sodium hyaluronate. May contain [+/-]: titanium dioxide CI 77891, iron oxides CI 77491/ CI 77492/ CI 77499

package

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

61354-022-01_AW61354-022-01_AW61354-022-01_AW61354-022-01_AW61354-022-01_AW61354-022-01_AW61354-022-01_AW61354-022-01_AW

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
61354-026-01cream30 mg in 1 TUBECREAM302

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
61354-026CREAM (OCTINOXATE, OXYBENZONE) CREAM [OXYGEN DEVELOPMENT]2Legacy NDC, 1 package rows20230211_bc07accc-5605-6c68-e053-2995a90a0a7e.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 18 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
61354-02661354-026-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 16 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
f45d0878-c1b5-4f9e-e053-2a95a90a2aa6bc07accc-5605-6c68-e053-2995a90a0a7e2023-02-10Exact identifier
spl id: f45d0878-c1b5-4f9e-e053-2a95a90a2aa6
spl set id: bc07accc-5605-6c68-e053-2995a90a0a7e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.